ARCHIVES

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

This article is from The Cancer Letter archive.

Vol. 33 No. 07 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review

February 13, 1987

Commercial Labs Open Drive To Get More NIH Business, Including Grants

April 26, 1974

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

April 28, 2006

Hospital to Review Medenica’s Privileges, With Conditions

November 5, 1993

Onco TCS Induces Responses In Relapsed Aggressive NHL

February 28, 2003

Chemoprevention Clinical Trials To starts In 1982 If Greenwald, DRCCA Board Can Move Fast Enough

August 28, 1981